According to the investigation data quoted by the Securities Times, it was established by an indirect wholly-owned subsidiary of China Biopharmaceutical Shanghai Runan Leung Hao Pharmaceutical Development Co., Ltd., with a registered capital of RMB 11 million. The company is mainly engaged in software development, goods import and export, import and export agents, personal business services, tax services, government procurement agency services and offshore trade operations, etc.
中國生物製藥(01177.HK)上海成立醫藥發展公司
Sino Biopharm (01177.HK) established a pharmaceutical development company in Shanghai.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.